Trial Profile
Pharmacokinetics of Oral Nalbuphine in Hemodialysis Patients with Uremic Pruritus
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Jun 2015
Price :
$35
*
At a glance
- Drugs Nalbuphine (Primary)
- Indications Pruritus
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Trevi Therapeutics
- 09 May 2014 Results presented at the at the 2014 Annual meeting of the society for Investigative Dermatology, according to Trevi Therapeutics media release.
- 07 May 2014 New trial record